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CASE REPORT
Primary Malignant Rhabdoid Melanoma
Bo Young Chung, M.D., In Su Ahn, M.D., Soo Ick Cho, M.D., Hye One Kim, M.D., 
Kwang Ho Kim, M.D., Chun Wook Park, M.D., Cheol Heon Lee, M.D.  
Department of Dermatology, College of Medicine, Hallym University, Seoul, Korea 
Melanoma with rhabdoid features is an uncommon variant 
of malignant melanoma. Here, we describe a rare case of 
primary rhabdoid malignant melanoma. A 54-year-old man 
presented with a black tumor measuring 3×4 cm on the right 
forearm. Histologic sections showed a tumor mass with 
rhabdoid features composed entirely of polygonal neo-
plastic cells with eccentric nuclei, prominent nucleoli, and 
large hyaline cytoplasmic inclusions. The tumor cells were 
immunoreactive with HMB-45, S100, Fontana-Masson 
silver and vimentin, and negative for smooth muscle actin, 
CD68, CD34, CD99, synaptophysin, desmin, and PAS. The 
differential diagnosis for this tumor included malignant 
peripheral nerve sheath tumor, malignant peripheral neu-
roectodermal tumor and rhabdomyosarcoma. The patient 
was treated with a wide excision and a local skin graft. The 
excised tumor was entirely composed of rhabdoid tumor 
cells. No recurrence or metastasis was evident 4 months after 
removal. This article is relevant to rare cases of primary 
malignant melanomas showing rhabdoid tumor cells over 





The term "rhabdoid tumor" was originally coined by Haas 
et al.
1 in 1981 to describe an aggressive childhood renal 
tumor, which was believed to represent a rhabdomyo-
sarcomatous variant of nephroblastoma. However, it did 
not exhibit ultrastructural evidence of rhabdomyoblastic 
differentiation. Histologically, neoplastic cells were cha-
racterized by a rhabdoid appearance with the presence of 
eccentric nuclei, single prominent nucleoli, and large 
hyaline cytoplasmic inclusions. Ultrastructurally, the 
tumor cells had a cytoplasmic paranuclear whorl of 
intermediate filaments containing an entrapped rough 
endoplasmic reticulum, mitochondria, and lipids
2. Since 
the original description of malignant rhabdoid tumors of 
the kidney, extrarenal rhabdoid tumors occurring in 
various sites such as the brain, spinal dura, lung, liver, 
colon, esophagus, ovary, uterus, vulva, bladder, skin, and 
soft tissue have been recognized and reported
3. 
Rhabdoid melanoma was first described in 1992 by 
Bittesini et al.
4. Since then, out of approximately 40 cases 
of melanomas with rhabdoid features that have been 
reported, only five have involved rhabdoid features in 
primary melanomas. Here, we report for the first time in 
Korea, the case of a 54-year-old Korean man with a 
primary rhabdoid melanoma on the right forearm.
CASE REPORT
A 54-year-old male presented with a black mass on his 
right forearm that had first developed 1 month earlier. 
Cutaneous examination revealed a solitary, well-defined 
sessile black tumor measuring 3×4 cm with a granulating 
protrusion in the central area of the right forearm (Fig. 1). BY Chung, et al
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Fig. 1. A solitary, well-defined sessile black tumor measuring 
3×4 cm with a granulating protrusion in the central area of the
right forearm.
Fig. 2. An ulcerated tumor nodule showed neoplastic prolife-
ration of polygonal cells with rhabdoid features and scattered 
melanin pigments (H&E, ×40).
Fig. 3. Tumor cells exhibited eosinophilic cytoplasm displacing 
a round eccentric vesicular nucleus with a prominent central 
nucleolus and a large intracytoplasmic hyalin inclusion (arrows)
(H&E, ×400). 
The remaining physical examination was unremarkable 
and the patient had no other significant health problems. 
Laboratory examinations, including blood and urine tests 
and chest X-ray, were within normal limits.
A punch biopsy was performed and histopathology 
showed an ulcerated tumor nodule containing neoplastic 
proliferation of polygonal cells with rhabdoid features and 
scattered melanin pigments (Fig. 2). The tumor was com-
posed entirely of neoplastic cells with eccentric nuclei, a 
single prominent nucleolus, and large hyaline cytoplasmic 
inclusions (Fig. 3). Immunohistochemistrically, the neo-
plastic cells were positive for HMB-45, S100, Fontana- 
Masson silver and vimentin, and negative for smooth 
muscle actin, CD68, CD34, CD99, synaptophysin, 
desmin, and PAS (Fig. 4). Vimentin staining showed 
diffuse and globular perinuclear accentuations (Fig. 4A). 
Therefore, we diagnosed the patient with rhabdoid 
melanoma, and performed PET-CT with no metastases. A 
wide excision with a 4 cm margin and split thickness skin 
graft was consequently performed. Histopathologic find-
ings were similar to previous punch biopsy results. The 
tumor’s Breslow thickness measured 9 mm, and it had a 
Clark level of 4. Four months after tumor removal, neither 
local recurrence nor metastasis occurred.
DISCUSSION
Malignant melanoma is known for its wide range of 
histological patterns. Melanoma variants that may mimic 
the morphologic and immunohistochemical features of 
non-melanocytic neoplasms include balloon cell melano-
ma, signet-ring cell melanoma, myxoid melanoma, small 
cell melanoma, and rhabdoid melanoma
5. Rhabdoid 
features are defined by morphologic characteristics such 
as eccentric nuclei, large nucleoli, and abundant 
cytoplasm containing hyaline filamentous inclusions, and 
are shaped like skeletal muscle cells. Rhabdoid melanoma 
exhibits significant histologic, immunohistochemical, and 
ultrastructural heterogeneity
3.
The extent of rhabdoid change among neoplastic cells 
varies. In Chang’s series
6, 48% (15 out of 31) of samples 
were composed exclusively of rhabdoid cells. In 52% (16 
out of 31) of samples, rhabdoid cells constituted less than 
25% of the tumor. In our case, the entire excised lesion 
was composed almost entirely of rhabdoid cells. The 
results of immunohistochemistry were variable. In a 
previous case, there was strong staining with S100 and Primary Malignant Rhabdoid Melanoma
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Fig. 4. Immunohistochemically, the neoplastic cells were positive for vimentin (A), S100 (B), Fontana-Masson silver (C) and HMB-45
(D), and negative for smooth muscle actin (E), CD68 (F), CD34 (G), CD99 (H), synaptophysin (I), desmin (J), and PAS (K). Vimentin 
staining showed intense, diffuse, and globular perinuclear accentuations (A) (A∼D: H&E, ×400, E∼K: H&E, ×200).
vimentin, but weak staining with neuron-specific enolase 
and epithelial membrane antigen
7. All three of Borek’s 
cases stained with S100 and vimentin, but none of them 
stained with HMB-45 and desmin
8. Our case exhibited 
positive reactivity to antibodies against S100, HMB-45, 
Fontana-Masson silver and vimentin, but showed negative 
staining from smooth muscle actin, CD68, CD34, CD99, 
synaptophysin, desmin, and PAS (Fig. 4). The pattern of 
vimentin staining was a diffuse and globular perinuclear 
accentuation (Fig. 4A). This may be informative in rhab-BY Chung, et al
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doid malenoma. In other studies a similar vimentin 
staining patternwas displayed
2,6,9. Further attention to this 
detail in future reports is required based on case studies to 
determine whether this type of vimentin staining pattern 
in rhabdoid malenoma is an unusual finding.
Because of the highly aggressive nature of some extrarenal 
rhabdoid and renal tumors, it may be expected that 
rhabdoid melanomas behave similarly. However, based 
on the cases reviewed here, rhabdoid melanoma appears 
to behave no more aggressively than conventional 
melanoma
3. Our case showed a distinctively rapid 
progression within about one month, and has so far not 
had any metastasis or local recurrence. Since a four-month 
follow-up period is not enough to assure prognosis, 
long-term follow-up will be required. To date, the 
prognosis of malignant rhabdoid melanoma is unknown, 
Fig. 4. Continued.Primary Malignant Rhabdoid Melanoma
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primarily because malignant rhabdoid melanoma is rarely 
occurring and has been reported infrequently. Prognosis 
of this disease could be better understood through more 
case reports. 
Differential diagnosis of a tumor with a rhabdoid 
phenotype is high. First, other possible clues to differential 
diagnosis in the tumor lesion besides rhabdoid appea-
rance are investigated. Then, other phenotypes can be 
excluded via a broad panel of immunohistochemical 
stains. Rhabdoid tumors are often positive for vimentin, 
glial fibrillary acidic protein, desmin, actin, and AE1/ 
AE3
7,10. Moreover, S100 protein expression is not ob-
served in renal rhabdoid tumors. The malignant peripheral 
nerve sheath tumor, especially the epithelioid variant, is 
positive for epithelial membrane antigen and synap-
tophysin, and is only focally positive for S100 protein. 
Plasmacytoma or plasmablastic lymphoma and anaplastic 
large cell lymphoma are likely to be positive for CD138 
and CD30, respectively. Rhabdoid morphology has been 
described in carcinoma, but lack of expression of both 
high- and low-molecular weight cytokeratins excludes an 
epithelial neoplasm, as well as epithelioid mesothelioma. 
Rhabdomyosarcoma may express muscle markers, such as 
desmin and myoglobin
11. Even though the rhabdoid 
phenotype in malignant melanomas is rarely occurring 
and reported infrequently, it should be included in the 
differential diagnosis of neoplasms with rhabdoid 
morphology
11.
Malignant rhabdoid melanoma appears mostly as a 
recurrent form, and only atypically as a primary lesion. Of 
the 40 cases of malignant rhabdoid melanomas reported, 
only five cases showed primary malignant rhabdoid 
melanomas. The histopathologic finding in most primary 
malignant rhabdoid melanoma rarely shows the tumor 
lesion wholly consisting of rhabdoid cells
7,8,12,13. How-
ever, in this case whole excision of the lesion was 
composed of tumor cells with rhabdoid features. Our 
results are meaningful for understanding rare cases of 
primary malignant melanoma showing rhabdoid featured 
malignant tumor cells over whole excision lesions.
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